Drug profile · INN
escitalopram
APO-ESCITALOPRAM
escitalopram (APO-ESCITALOPRAM) is a serotonin transporter inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 16
News articles 1
Drug details — escitalopram
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 16
- Data quality
- 0.81
Quick answer
escitalopram (APO-ESCITALOPRAM) is a serotonin transporter inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN escitalopram
Brand APO-ESCITALOPRAM
Mechanism Serotonin transporter inhibitor
Originator Alphapharm Pty Ltd
Mechanism of action
Serotonin transporter inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Frequently asked questions
What is escitalopram?
escitalopram (APO-ESCITALOPRAM) is a serotonin transporter inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for escitalopram?
APO-ESCITALOPRAM is a marketed brand name for escitalopram. Check FDA Drugs@FDA for the current US label holder and prescribing information.